Skip to navigation Skip to content

Zinbryta

Share

About this Medication
  • Brand Name: Zinbryta
  • Chemical Name: daclizumab (dak-li-zoo-mab)
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This medication is taken by injection.

 

Description

Zinbryta™ is a laboratory-created monoclonal antibody. It is designed to inhibit certain inflammatory functions of T cells and increase important immune cells that help regulate the immune system.  
Zinbryta is approved by the U.S. Food and Drug Administration (FDA) to treat adult patients with relapsing forms of MS. It should be reserved for people who have had an inadequate response to two or more disease-modifying medications.  
 
Click here to read the Zinbryta Prescribing Information for healthcare professionals.
Click here to read the Zinbryta Medication Guide for patients.

Support

Zinbryta™ Patient Support Program
Above MS
1-800-456-2255
www.AboveMS.com
 

Financial Assistance Program

Above MS
1-800-456-2255
www.abovems.com

Share